These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 6727657

  • 21. Reappraisal of bromocriptine treatment for acromegaly.
    Maneschi F.
    Horm Res; 1980; 12(4):191-205. PubMed ID: 7390405
    [Abstract] [Full Text] [Related]

  • 22. Bomocriptine treatment of patients with acromegaly resistant to conventional therapy.
    Pelkonen R, Ylikahri R, Karonen SL.
    Clin Endocrinol (Oxf); 1980 Mar; 12(3):219-24. PubMed ID: 6993053
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Bromocriptine therapy in eleven patients with acromegaly.
    Lundin L, Ljunghall S, Wide L, Boström H.
    Acta Endocrinol Suppl (Copenh); 1978 Mar; 216():207-16. PubMed ID: 347863
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.
    Lamberts SW, Zweens M, Verschoor L, del Pozo E.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):16-9. PubMed ID: 2872225
    [Abstract] [Full Text] [Related]

  • 27. Bromocriptine therapy in acromegaly.
    Sachdev Y, Gomez-Pan A, Tunbridge WM, Duns A, Weightman DR, Hall R, Goolamali SK.
    Lancet; 1975 Dec 13; 2(7946):1164-8. PubMed ID: 53655
    [Abstract] [Full Text] [Related]

  • 28. [Effect of dopaminergic stimulation on growth hormone and prolactin in the treatment of acromegaly].
    Nedvídková J, Felt V.
    Vnitr Lek; 1980 Oct 13; 26(10):988-93. PubMed ID: 7467150
    [No Abstract] [Full Text] [Related]

  • 29. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
    Hanew K, Sasaki A, Mouri T, Yoshinaga K.
    Acta Endocrinol (Copenh); 1980 Nov 13; 95(3):298-307. PubMed ID: 6776756
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
    Nortier JW, Croughs RJ, Donker GH, Thijssen JH, Schwarz F.
    Acta Endocrinol (Copenh); 1984 Jun 13; 106(2):175-83. PubMed ID: 6145276
    [Abstract] [Full Text] [Related]

  • 33. Bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J, Haugen HN, Bohmer T.
    Acta Endocrinol (Copenh); 1977 Nov 13; 86(3):464-72. PubMed ID: 335755
    [Abstract] [Full Text] [Related]

  • 34. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM, Atkinson AB, Hadden DR, Kennedy L, Leslie H, Merrett JD, Sheridan B.
    Arch Intern Med; 1986 Jun 13; 146(6):1145-9. PubMed ID: 3718102
    [Abstract] [Full Text] [Related]

  • 35. [Effect of CB-154 on acromegaly].
    Kato Y, Iwasaki Y, Chihara K, Imura H.
    Horumon To Rinsho; 1977 Dec 13; 25(12):1332-6. PubMed ID: 598038
    [No Abstract] [Full Text] [Related]

  • 36. [Therapy of acromegaly using bromocriptine].
    Köbberling J, Schwinn G, Dirks H.
    Dtsch Med Wochenschr; 1975 Jul 18; 100(29):1540-2. PubMed ID: 1149634
    [Abstract] [Full Text] [Related]

  • 37. [Bromocriptin treatment of acromegaly (author's transl)(proceedings)].
    Bricaire H, Strauch G, Boutonnat Y.
    Ann Endocrinol (Paris); 1976 Jul 18; 37(4):301-2. PubMed ID: 1037361
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM, Wass JA.
    Med J Aust; 1978 Nov 04; 2(3 Suppl):31-3. PubMed ID: 745579
    [Abstract] [Full Text] [Related]

  • 40. Some properties of the plasma hGH activity in patients with Laron-type dwarfism determined by a radioreceptor assay using human liver tissue.
    Eshet R, Peleg S, Josefsberg Z, Fuchs C, Arnon R, Laron Z.
    Horm Res; 1985 Nov 04; 22(4):276-83. PubMed ID: 3000911
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.